The state of South Dakota currently has 3 active clinical trials seeking participants for Alzheimer's Disease research studies. These trials are conducted in various cities, including Sioux Falls, Rapid City, Watertown and Aberdeen.
A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3)
NCT05026866
Recruiting
The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD).
Gender:
All
Ages:
Between 65 years and 80 years
Trial Updated:
06/17/2024
Locations: Health Concepts, Rapid City, South Dakota
Conditions: Alzheimer Disease
Register for Updates
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)
NCT05531526
Recruiting
This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to evaluate the efficacy and safety of AR1001 for the treatment of participants with early AD.
Gender:
All
Ages:
Between 55 years and 90 years
Trial Updated:
06/06/2024
Locations: Health Concepts, Rapid City, South Dakota
Conditions: Alzheimer Disease
Register for Updates
Alzheimer's Disease and Precision Medicine Research Among Native People
NCT03448601
Recruiting
This project intends to address the gaps in Alzheimer's disease (AD) and precision medicine (PM) research in American Indian and Alaska Native (AI/AN) populations by comparing written and video-based materials for recruitment into AD and PM research, and by creating an AD-PM registry of AI/AN individuals who are willing to be contacted for future research opportunities.
Gender:
All
Ages:
Between 40 years and 100 years
Trial Updated:
10/30/2023
Locations: Missouri Breaks Industries Research, Inc., Rapid City, South Dakota
Conditions: Alzheimer Disease
Register for Updates